Funded Insurance Startups
Recent insurance + AI B2B software rounds shown here cluster tightly in late 2025: the five entries span 2025-09-29 (Rehuman) through 2025-11-06 (Avallon L…
Recent insurance + AI B2B software rounds shown here cluster tightly in late 2025: the five entries span 2025-09-29 (Rehuman) through 2025-11-06 (Avallon Labs). Within that window, the disclosed amounts show one clear size outlier: Liberate Innovations’ 2025-10-14 Series B is $50M, which sits well above the rest of the disclosed rounds ($13M for Irys Insurtech on 2025-10-16 and $5M for Avallon Labs on 2025-11-06). Two additional entries (Silas Insurtech on 2025-10-03 and Rehuman on 2025-09-29) have undisclosed amounts, so the visible distribution is incomplete but still highly skewed by the $50M round.
Geographically, the set is distributed across four locations (New York, Tampa, Palo Alto, and London), with two US cities and one UK presence; however, the two undisclosed entries land in a different geography mix (Silas is listed without a city, and Rehuman is London). Stage-wise, the visible mix runs from Pre-Seed (Silas Insurtech) through Seed (Avallon Labs, Irys Insurtech, Rehuman) and includes a single Series B (Liberate Innovations).
Most recent rounds
5 shownRelated listings
Frequently asked
Which disclosed round is largest in this insurance + AI B2B software slice, and how does it compare to the others?
Liberate Innovations’ 2025-10-14 Series B at $50M dwarfs the other disclosed amounts, which top out at $13M (Irys Insurtech, 2025-10-16) and $5M (Avallon Labs, 2025-11-06). The two 2025-10-03 (Silas Insurtech) and 2025-09-29 (Rehuman) entries are undisclosed, so comparisons rely on the remaining three disclosed rounds.
Do these rounds cluster in time, or are they spread out?
They cluster in late 2025, spanning just 38 days from 2025-09-29 (Rehuman) to 2025-11-06 (Avallon Labs). Four of the five entries fall in October 2025 (2025-10-03, 2025-10-14, 2025-10-16, plus the 2025-09-29 baseline).
Is there a city or geography concentration, or is it dispersed?
It is dispersed across New York (Avallon Labs, 2025-11-06), Tampa (Irys Insurtech, 2025-10-16), Palo Alto (Liberate Innovations, 2025-10-14), and London (Rehuman, 2025-09-29). One entry (Silas Insurtech, 2025-10-03) is listed with no city, so there is no clear single-city concentration in the shown rows.
What stage mix dominates these five rows?
Seed appears most often among named amounts and stages: Avallon Labs (Seed, 2025-11-06), Irys Insurtech (Seed, 2025-10-16), and Rehuman (Seed, 2025-09-29). The set also includes one Series B (Liberate Innovations, 2025-10-14) and one Pre-Seed (Silas Insurtech, 2025-10-03), plus two entries with undisclosed amounts.
Are there notable outliers besides the $50M round?
Yes. Even ignoring stage, the combination of one very large disclosed round ($50M on 2025-10-14 by Liberate Innovations) and two undisclosed rounds (Silas Insurtech on 2025-10-03 and Rehuman on 2025-09-29) makes the disclosed distribution visibly skewed. Among disclosed entries only, the gap between $13M (Irys Insurtech) and $5M (Avallon Labs) is meaningful, with no other disclosed rounds filling the middle.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.